Table 2.
Significant Drug Clusters Described in Text. Drugs were clustered in an unsupervised manner by their predicted therapeutic score across 100 diseases (See Fig.3a)
| Drug Group | Drugs |
|---|---|
| PI3K Inhibitors | LY−294002 and wortmannin |
| HSP90 | geldanamycin, raloxifene, monorden, and sodium phenylbutyrate |
| HDAC Inhibitors | vorinostat, HC toxin, and trichostatin A |
| Salicylate anti-inflammatory | sulfasalazine, mesalazine, and acetylsalicylic acid |